Macquarie Group
NEUE

Macquarie Group’s NeueHealth NEUE Stock Holding History

Macquarie Group’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-743
Closed -$485K – 2651
2021
Q3 		$485K Buy
743
+52
+8% +$45.7K ﹤0.01% 1684
2021
Q2 		$948K Buy
+691
New +$947K ﹤0.01% 1608

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Macquarie Group's NEUE Position: Q4 2021 in Review

Macquarie Group sold out of NeueHealth (NEUE) in Q4 2021, closing a stake of 743 shares — an estimated $485K sold.

Macquarie Group first reported a position in NEUE in Q2 2021 and held it in 2 quarters. The position peaked at $948K in Q2 2021. 117 funds tracked by Wall St. Rank hold NEUE as of Q4 2021.

  • Macquarie Group reported no remaining NeueHealth position as of Q4 2021 after selling out during the quarter.
  • Macquarie Group sold 743 NeueHealth shares in Q4 2021, an estimated $485K.
  • Macquarie Group first reported a position in NeueHealth in Q2 2021 and held it in 2 quarters.
  • Macquarie Group's NeueHealth position peaked at $948K in Q2 2021.
  • 117 funds tracked by Wall St. Rank held NeueHealth as of Q4 2021.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.